Form type | Sec Links | Description | Filing date | Reporting date |
---|---|---|---|---|
SC 13G/A | Report | Mar 19, 2024 | ||
SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
SC 13G | Report | Feb 14, 2024 | ||
SC 13G/A | Report | Feb 13, 2024 | ||
SC 13G/A | Report | Feb 7, 2024 | ||
SC 13G/A | Report | AMENDMENT NO. 1 | Jan 19, 2024 | |
SC 13G | Report | Nov 3, 2023 | ||
SC 13G/A | Report | Jul 10, 2023 | ||
SC 13G | Report | SC 13G | Feb 14, 2023 | |
SC 13G/A | Report | Feb 14, 2023 | ||
SC 13G/A | Report | Feb 9, 2023 | ||
SC 13G/A | Report | JHG PLC OWNS <5% | Feb 9, 2023 | |
SC 13G/A | Report | SC 13G/A | Feb 2, 2023 | |
SC 13G | Report | NONE | Jan 26, 2023 | |
SC 13G/A | Report | SC 13G/A | Aug 15, 2022 | |
SC 13G/A | Report | CYTEIR THERAPEUTICS, INC. | Feb 14, 2022 | |
SC 13G | Report | SC 13G | Feb 14, 2022 | |
SC 13G | Report | SC 13G | Feb 14, 2022 | |
SC 13G | Report | Feb 14, 2022 | ||
SC 13G | Report | JANUS HENDERSON GROUP PLC OWNS >5% | Feb 11, 2022 | |
SC 13G/A | Report | Feb 9, 2022 | ||
SC 13G | Report | SC 13G | Feb 3, 2022 | |
SC 13G | Report | Oct 12, 2021 | ||
SC 13G | Report | CYTEIR THERAPEUTICS, INC. | Jun 29, 2021 |